ADMA Biologics, Inc. (ADMA) vs Nurix Therapeutics, Inc. (NRIX)

A side-by-side comparison of ADMA Biologics, Inc. and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADMA vs NRIX

growth of $100 · dividends reinvested · last 6y
ADMA +216.9% (+21.2%/yr)NRIX +20.4% (+3.1%/yr)ADMA compounded faster over this window
0200400600800Start $100202120222023202420252026$317$120
ADMA NRIX

ADMA vs NRIX: by the numbers

  • •ADMA is the larger company ($2.36B vs $2.35B market cap).
  • •ADMA is profitable (32.98% net margin) while NRIX runs a net loss (-928.44%).
  • •ADMA grew revenue faster over the past five years (54.55% vs 9.96% CAGR).

Metrics side by side

Valuation

MetricADMANRIX
P/E ratio14.53N/A
Forward P/E12.77N/A
P/S ratio4.6063.87
P/B ratio5.775.83
EV / EBITDA10.73N/A
FCF yield4.94%N/A

Profitability

MetricADMANRIX
Gross margin64.71%77.55%
Operating margin42.26%-340.16%
Net margin32.98%-928.44%
ROE41.39%-84.78%
ROIC27.60%-77.92%

Growth (annualized)

MetricADMANRIX
Revenue CAGR (5Y)54.55%9.96%
Total return CAGR (5Y)54.74%-5.51%

Frequently asked

Which has grown faster, ADMA or NRIX?
Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus NRIX at 9.96%.
Is ADMA or NRIX more profitable?
ADMA runs the higher net margin — ADMA at 32.98% versus NRIX at -928.44%.
How have ADMA and NRIX total returns compared?
Over the past 5 years, ADMA delivered 54.74% and NRIX delivered -5.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.